Filing Details
- Accession Number:
- 0001104659-21-026467
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-23 08:04:47
- Reporting Period:
- 2021-02-22
- Accepted Time:
- 2021-02-23 08:04:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1772028 | Scopus Biopharma Inc. | SCPS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1665280 | R Joshua Lamstein | C/O Scopus Biopharma Inc. 420 Lexington Avenue, Suite 300 New York NY 10170 | Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 | Acquisiton | 2021-02-22 | 100 | $9.99 | 116,797 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
